Align Technology’s Rollouts Aid Amid Procedural Deferrals

Mabel R. Acton

On Jul 6, we issued an updated research report on Align Technology, Inc. ALGN. The company is riding on solid product development and continued focus on international markets. However, the current economic unrest is likely to adversely impact Align Technology’s dental procedures. The stock carries a Zacks Rank #3 (Hold), at present.

Despite all COVID-19-led deferral of procedures, in the first quarter 2020, Align Technology’s Invisalign shipment volumes improved, reflecting solid growth from non-comprehensive products, stemming from strong adoption of Invisalign Go and Invisalign Moderate systems. Within iTero, the company’s buyout of Exocad is expected to strengthen the company’s position

Read More

Subscribe US Now